Abstract
Hereditary spastic paraplaegias are a group of clinically and genetically heterogeneous neurodegenerative disorders characterised by progressive spasticity and weakness in the lower limbs. The most common forms of hereditary spastic paraplaegia are SPG4 and SPG3A caused by sequence variants in the SPAST and ATL1 genes, as well as by deletions and duplications not detected by standard techniques. In this study, we used the multiplex ligation-dependent probe amplification (MLPA) analysis for screening 93 patients (52 familial and 41 isolated cases). As a result, we identified 11 different deletions and 1 duplication in the SPAST gene and a single exon deletion in the ATL1 gene. These results indicate that micro-rearrangements in the SPAST gene are a fairly frequent cause of hereditary spastic paraplaegia and that MLPA is a useful and efficient technique to detect a considerable proportion of the mutations in the most common forms of hereditary spastic paraplaegias.
This is a preview of subscription content, log in via an institution to check access.
References
Schwarz GA, Liu CN (1956) Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. AMA Arch Neurol Psychiatry 75:144–162
Behan WM, Maia M (1974) Strumpell’s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37:8–20
Harding AE (1993) Hereditary spastic paraplegias. Semin Neurol 13:333–336
Krabbe K, Nielsen JE, Fallentin E et al (1997) MRI of autosomal dominant hereditary spastic paraplegia. Neuroradiology 39:724–727
Gasser T, Finsterer J, Baets J et al (2010) EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias. Eur J Neurol 17:179–188
McDermott CJ, Burness CE, Kirby J et al (2006) Clinical features of hereditary spastic paraplegia due to spastin mutations. Neurology 67:45–51
Shoukier M, Neesen J, Sauter SM et al (2009) Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia. Eur J Hum Genet 17:187–194
Beetz C, Nygren AO, Schickel J et al (2006) High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67:1926–1930
Depienne C, Fedirko E, Forlani S et al (2007) Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet 44:281–284
Dürr A, Camuzat A, Colin E et al (2004) Atlastin 1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 61:1867–1872
Mitne-Neto M, Kok F, Beetz C et al (2007) A multi-exonic SPG4 duplication underlies sex-dependent penetrance of hereditary spastic paraplegia in a large Brazilian pedigree. Eur J Hum Genet 15:1276–1279
Beetz C, Nygren AOH, Deufel T, Reid E (2007) An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion. Neurogenetics 8:317–318
Alvarez V, Sanchez-Ferrero E, Beetz C et al (2010) Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol 10:89. http://www.biomedcentral.com/1471-2377/10/89
Acknowledgments
The study was supported by Operational Programme Innovative Economy, Activity 1.1.2 (UDA-POIG.01.01.02-14-051/09-00).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sulek, A., Elert, E., Rajkiewicz, M. et al. Screening for the hereditary spastic paraplaegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals. Neurol Sci 34, 239–242 (2013). https://doi.org/10.1007/s10072-011-0899-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0899-3